# A Study of LY2940680 in Healthy Participants

> **NCT01681186** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 30 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** LY2940680 Capsule(s) (Reference)
- **DRUG:** LY2940680 Tablet (Test)
- **DRUG:** Lansoprazole
- **DRUG:** Placebo Capsule(s)

## Key facts

- **NCT ID:** NCT01681186
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01681186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01681186, "A Study of LY2940680 in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01681186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*